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SuccinateCitric acid cycle intermediates, including succinate and citrate, are absorbed across the apical membrane by
the NaDC1 Na+/dicarboxylate cotransporter located in the kidney and small intestine. The secondary
structure model of NaDC1 contains 11 transmembrane helices (TM). TM7 was shown previously to contain
determinants of citrate afﬁnity, and Arg-349 at the extracellular end of the helix is required for transport. The
present study involved cysteine scanning mutagenesis of 26 amino acids in TM7 and the associated loops. All
of the mutants were well expressed on the plasma membrane, but many had low or no transport activity: 6
were inactive and 7 had activity less than 25% of the parental. Three of the mutants had notable changes in
functional properties. F336C had increased transport activity due to an increased Vmax for succinate. The
conserved residue F339C had very low transport activity and a change in substrate selectivity. G356C in the
putative extracellular loop was the only cysteine mutant that was affected by the membrane-impermeant
cysteine reagent, MTSET. However, direct labeling of G356C with MTSEA-biotin gave a weak signal, indicating
that this residue is not readily accessible to more bulky reagents. The results suggest that the amino acids of
TM7 are functionally important because their replacement by cysteine had large effects on transport activity.
However, most of TM7 does not appear to be accessible to the extracellular ﬂuid and is likely to be an outer
helix in contact with the lipid bilayer.porter family; MTSEA-biotin,
-(trimethylammonium)ethyl]-
otransporter 1; PMSF, phenyl-
family 13; TM, transmembrane
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Metabolic intermediates from the citric acid cycle, including
succinate, citrate, and α-ketoglutarate, are transported across the
plasma membrane by sodium-coupled transporters from the SLC13
family [1]. The low-afﬁnity Na+/dicarboxylate cotransporter, NaDC1,
is located on the apical membrane of renal proximal tubule and small
intestinal cells. NaDC1 couples the transport of three sodium ions with
one divalent anion substrate [2,3]. In the kidney, NaDC1 helps regulate
urinary concentrations of citrate and succinate, which may have
effects on the development of kidney stones or regulation of blood
pressure [4,5]. NaDC1 also participates in organic anion secretion by
contributing dicarboxylates to the organic anion exchangers [6].
The secondary structure of NaDC1 is predicted to have 11
transmembrane helices (TM), with an intracellular amino terminusand an extracellular carboxy terminus [7] (Fig. 1A). The carboxy
terminus contains the conserved N-glycosylation site at Asn-578 [8].
Two prolines at each end of TM7 have been shown to affect transport
activity; Pro-327 appears to be important for protein function,
whereas Pro-351 is important for trafﬁcking to the plasma membrane
[9]. TM7 also contains residues that determine differences in citrate
and sodium Km between the rabbit and human NaDC1 [10]. Finally,
Arg-349 at the extracellular surface of TM7 is important for substrate
and cation binding [11].
Our previous study involved a cysteine scan at the extracellular
surface of TM7, between Leu-344 to Phe-354, including Arg-349 [12]. In
the present study we extended the cysteine scan to include the rest of
TM7 and the associated loops, from Gln-321 to Trp-357. Despite high
expression on the plasmamembrane,many of the cysteinemutants had
low activity or were inactive. Some of the TM7mutants had changes in
functional properties: F339C had altered succinate:citrate substrate
selectivity and F336Chadan increased substrateVmax. Onlyoneof the26
mutants, G356C, predicted to be in the extracellular loop, was inhibited
by chemical labeling with membrane-impermeant cysteine selective
reagents. The results suggest that the amino acids of TM7 are
functionally important, because their replacement by cysteine had
large effects on transport activity. However, TM7 does not appear to be
accessible to the extracellular solvent and it is likely to be an outer helix.
AB
Fig. 1. (A) Secondary structure model of NaDC1. The numbered rectangles represent TMs, and the Y represents N-glycosylation. The inside of the cell is at the bottom of the ﬁgure.
The model indicates the positions of Pro-327, Arg-349, and Pro-351 in TM7, shown in our previous studies to be important for function [12,13]. (B) Multiple sequence alignment of
TM7 and connecting loops in members of the SLC13 family. The amino acid numbering of the TM7 sequence alignment (321–357, shown above the sequences) is based on the
rbNaDC1 sequence. The GenBank accession numbers of the nucleotide sequences are shown next to the names. The amino acids mutated in this study (321–343, 355–357) are
shown in white lettering on a black background, and conserved amino acids are shown with grey backgrounds. The line below the sequences indicates the approximate position of
transmembrane helix 7 and the orientation is inside (left) to outside (right).
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2.1. Site-directed mutagenesis
Twenty-six acids in transmembrane helix (TM) 7 and associated
loops of rbNaDC1 were individually mutated to cysteines using the
QuikChange site-directed mutagenesis kit (Stratagene). The mutants
were made in a background of 4N, a reduced cysteine mutant of
NaDC1 containing four out of eleven endogenous cysteines at the
N-terminus (positions 4, 38, 50, and 64), in the pcDNA3.1 vector
(Invitrogen). NaDC1 requires at least four cysteines for expression [13]
and the 4N mutant is not sensitive to membrane-impermeant
methanethiosulfonate reagents, such as MTSET.
2.2. Expression of NaDC1 cysteine mutants in COS-7 cells
Mutants were expressed in COS-7 cells, as described previously
[14]. Brieﬂy, the cells were cultured in Dulbecco's modiﬁed Eagle's
medium containing Glutamax and 25 mM HEPES (Invitrogen, Carls-
bad, CA) supplemented with 10% heat-inactivated fetal calf serum,
100 U/ml penicillin and 100 μg/ml streptomycin at 37 °C in 5% CO2.
Cells were plated on collagen-coated plates at 0.6×105 cells per well
(24 wells) or 1.5×105 cells/well (6 wells) and transfected using
Fugene 6 (Roche) at a 9:3 ratio (1.8 μl Fugene 6 and 0.6 μg plasmid
DNA) for 24-well plates or a 3:1 ratio (3 μl Fugene 6 and 1 μg plasmid
DNA) for 6-well plates.
2.3. Transport assays
Transport assays were carried out 48 h after transfections, also as
described [14,15]. The sodium buffer contained the following in
millimolar: 140 NaCl, 2 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES, pH adjusted
to 7.4 with 1 M Tris. Choline buffer contained equimolar choline Cl inplace of NaCl. For the assays, eachwell was washed twice with choline
buffer to remove medium, then incubated with sodium buffer
containing [2,3-14C]-succinate (~50 mCi/mmol, ~20 μM, Moravek)
for 30 min at room temperature. The uptake assays were stopped and
radioactivity washed away with four washes of choline buffer. The
wash volume was 1 ml (24-well plates) or 3 ml (6-well plates), and
the transport buffer volume was 0.25 ml (24-well plates) or 1 ml (6-
well plates). Cells were dissolved in 1% SDS, transferred to scintillation
vials, and counted. For all experiments, uptakes in vector-transfected
cells were subtracted from uptakes in NaDC1 plasmid-transfected
cells to correct for background counts. Transport experiments
involving the G356C mutant were done at 37 °C to increase the
signal. In NaDC1, temperature affects the Vmax but not the Km (results
not shown).
Transport experiments involving methanethiosulfonate (MTS)
reagents were also done as described previously [15]. Brieﬂy, the
cells were preincubated in freshly prepared [2-(trimethylammonium)
ethyl]methanethiosulfonate bromide (MTSET, Toronto Research
Chemicals) or buffer alone for 10 min at room temperature. The
preincubation solution was removed and the cells were washed, then
the transport activity in the cells was assayed using 14C-succinate as
described above. The transport activity after MTSET treatment is
expressed as a percentage of the control group preincubated with
buffer only.2.4. Transport speciﬁcity ratio measurements
For transport speciﬁcity ratio (TSR) measurements, dual-label
transport assays were done involving both 10 μM [3H]succinate and
20 μM [14C]citrate in sodium buffer, as described previously [16]. The
transport speciﬁcity ratio was calculated using TSR=(νsuccinate/
νcitrate)×([citrate]/[succinate]) where νsuccinate and νcitrate are the
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[succinate] are the concentrations of citrate and succinate.
2.5. Cell-surface biotinylations
The cell-surface expression of NaDC1 mutants in COS-7 cells was
determined using the membrane-impermeant reagent, Sulfo-NHS-
LC-biotin (Pierce), also as described previously [15]. Brieﬂy, each well
of cells in 6-well plates was washed 3× with 3 ml PBS pH 9 containing
1 mM each Ca2+ and Mg2+ (PBS/CM), then incubated 30 min at room
temperature with 0.5 ml 1.5 mg/ml Sulfo-NHS-LC-biotin (Pierce)
prepared in PBS-CM, followed by 20 min on ice with 3 ml cold Quench
buffer (PBS/CM with 100 mM glycine). Lysis buffer (0.5 ml per well)
(1% Triton X-100, 150 mM NaCl, 5 mM EDTA, 20 mM Tris, pH 7.5
supplemented with 10 μg/ml pepstatin, 10 μg/ml leupeptin, and
0.5 mM phenylmethylsulfonylﬂuoride) was added followed by 30-
min incubation on ice with rocking. The lysed cells were pelleted, and
the supernatantswere incubatedwith 50 μl Immunopure Immobilized
Streptavidin (Pierce) overnight at 4 °C with end-over-end rotation.
The next day the beads were washed and the samples were used in
Western blotting. Blots were incubated with 1:1000 dilution of anti-
NaDC1 antibodies, raised in rabbits against a fusion protein of NaDC1
[8], followed by 1:7500 dilution of peroxidase-conjugated anti-rabbit
IgG secondary antibody (Jackson Labs). Detection was done using
Pierce Supersignal West Pico chemiluminescent substrate and Image
Station 4000R (Carestream Scientiﬁc).
2.6. Labeling of cysteine mutants with MTSEA-biotin
NaDC1 cysteine mutants were directly labeled with MTSEA-biotin
as described previously [15]. Speciﬁc labeling was determined by
preincubation with MTSET. The mutants were expressed in HeLa cells
(ATCC CCL-2) because the background signal was lower. The cells
were pretreated ﬁrst with 5 mM dithiothreitol, followed by 1 mM
MTSET in sodium transport buffer or sodium buffer alone for 10 min at
room temperature. Cells were washed 3 times with 3 ml of PBS/CM,
pH 7.5, then treated with 0.5 ml of 0.1 mM N-biotinylaminoethyl
methanethiosulfonate (MTSEA-biotin) (Toronto Research Chemicals)
in PBS/CM, pH 7.5 for 10 min. The MTSEA-biotin was prepared as a
200 mM stock solution in dimethylsulfoxide. After the incubation,
wells were washed 3 times with 3 ml of PBS/CM, pH 7.5. Lysis buffer
with protease inhibitors was added to the plates, which were kept on
ice with rocking for cell lysis. The remaining steps were identical to
those of the cell-surface biotinylation procedure. Biotinylated proteins
were identiﬁed by Western blotting with anti-NaDC1 antibodies.
2.7. Statistics
Duplicate or quadruplicate measurements were made for each
data point. The experiments were repeated with at least three
different batches of transfected cells from different passage numbers.
Signiﬁcant differences between groups were identiﬁed by Student's
t-test or ANOVA with Pb0.05. Data are reported as means±SEM.
3. Results
3.1. Cysteine scanning mutagenesis of TM7 and associated loops
Twenty-six amino acids from Gln-321 to Trp-357, a region that
includes transmembrane helix (TM) 7, were individually mutated to
cysteine. Amino acids Leu-344 through Phe-354 were not included
because they were tested in a previous cysteine scan [12]. The
parental transporter for this study was the reduced-cysteine 4N
mutant of NaDC1, containing four out of the eleven endogenous
cysteines [13]. At least four cysteines are required for correct
processing of NaDC1 to the plasma membrane, and the 4N mutantis insensitive to inhibition by membrane-impermeant methanethio-
sulfonate reagents. The sequence alignment of the TM7 region from
NaDC1 and other mammalian members of the SLC13 family is shown
in Fig. 1B.3.2. Cell-surface expression of TM7 mutants
Western blots of TM7 cysteine mutants are shown in Fig. 2. COS-7
cells expressing the mutants were treated with a membrane-
impermeant reagent, Sulfo-NHS-LC-biotin, that labels extracellular
lysine residues. All of the biotinylated cell-surface proteins were then
precipitated with streptavidin beads, separated on SDS-PAGE and
transferred to nitrocellulose. Anti-NaDC1 antibodies were then used
to identify the biotinylated NaDC1 mutants located on the plasma
membrane. Images of single blots are shown in Fig. 2, and the
summary of 3–4 blots is shown in Fig. 3 (right side). The succinate
transport activity of the cysteine mutants is also shown in Fig. 3 (left
side). Most of the mutants were well expressed on the plasma
membrane compared with the 4N parental transporter. Six of the
mutants had signiﬁcantly lower protein abundance: G326C, P327C,
S329C, F336C I337C, and V340C. In contrast, the W357C mutant
protein abundance was higher than that of the 4N parental (Fig. 3).
Despite relatively high protein expression, many of the mutants had
low transport activity, including ﬁve mutants that were completely
inactive: Q321C, G326C, A331C, E332C, and W357C. When expressed
as a percentage of cell-surface protein abundance, the transport
activity of the F336C, V340C, and L342C mutants was signiﬁcantly
greater than the 4N parental (Fig. 4). Of the mutants with measurable
transport activity, the Y322C, R323C, L324C, L325C, P327C, F330C,
K333C, A334C, V335C, F339C, V343C, and G356C mutants had much
lower activity relative to protein expression (Fig. 4).3.3. Substrate selectivity between succinate and citrate
Our previous study suggested that TM7 contains determinants of
citrate afﬁnity [10]. Therefore, the transport speciﬁcity ratio (TSR)was
used to identify any changes in succinate:citrate substrate selectivity
in the TM7 cysteine mutants. The transport speciﬁcity ratio is
independent of protein expression and is very useful for screening
mutants with low transport activity [17]. As shown in Fig. 5, only the
F339C mutant had a signiﬁcant decrease in TSR. The other mutants,
despite decreases in transport activity, had no change in the ratio. It
should be noted that because the TSR is a ratio, it detects changes in
substrate selectivity of succinate relative to citrate but does not
identify changes in the kinetics of both substrates.3.4. Succinate transport kinetics
The succinate kinetics of the F336Cmutant was comparedwith the
4N parental transporter to determine whether this could account for
the increased transport activity. As shown in Fig. 6, there was a
signiﬁcant increase in the Vmax for succinate in F336C compared with
4N, but no signiﬁcant differences in Km. In the experiment shown in
Fig. 6, the 4N transporter had a succinate Km value of 23 μMand a Vmax
of 12 pmol/min-well. The mean of four experiments was 18±3 μM
(Km) and 8±2 pmol/min-well (Vmax). The F336C mutant had a Km for
succinate of 15 μM(experiment shown in Fig. 6) and ameanKm of 17±
1 μM (n=3). The Vmax for succinate in F336C was 20 pmol/min-well
(Fig. 6) and a mean Vmax of 19±2 pmol/min-well. It should be noted
that the succinate Km in NaDC1 varies between experiments, for
unknown reasons. The values reported here are similar to the Km of
25 μM in our previous experiments using COS-7 cells [18]. However, in
other experiments, also using COS-7 cells, the Km was around 100 μM
[19].
Fig. 2. Western blots of cell-surface protein expression. COS-7 cells expressing the TM7 cysteine mutants were treated with the membrane-impermeant reagent, Sulfo-NHS-LC-
biotin as described in Methods. Western blots were probed with anti-NaDC1 antibodies. The positions of MagicMark size standards at 50 and 60 kDa are in the ﬁrst lane of each blot.
Some lanes have been removed from the image, shown by a gap after G356C.
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The TM7 cysteine mutants were tested for their sensitivity to the
membrane-impermeant reagent, MTSET. The T482C mutant was
included in each experiment to verify that the MTSET was active;
this mutant was shown in our previous study to be very sensitive to300 200 100
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Fig. 3. Summary of transport activity and protein expression of the TM7 cysteine mutants. Su
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from the same blot. Data shown are means±SEM, n=3–6 experiments (transport) except
experiments (Western blots). The dotted lines show the 100% values and asterisk (*) indicinhibition by MTSET [13]. Out of 26 cysteine mutants in the present
study, only G356C was signiﬁcantly inhibited by MTSET treatment
(Fig. 7). The accessibility of G356C to extracellular MTSET was tested
under different conditions, the presence or absence of sodium and
sodium together with 10 mM succinate. As shown in Fig. 8, the 4N
parental transporter was not inhibited by MTSET under any% 4N
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ccinate transport activity relative to the 4N control is shown on the left side (increasing
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protein signals from Western blots (such as in Fig. 2), relative to the abundance of 4N
for the W357C and Q321C transport experiments, which were repeated twice; n=3–4
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Fig. 4. Succinate transport activity relative to cell-surface protein abundance in the NaDC1 cysteine mutants. The transport activity (shown in Fig. 3) was expressed as a percentage of
the mean cell-surface protein abundance. Data shown are means±SEM, n=3–6 experiments except for the W357C and Q321C transport experiments, which were repeated twice.
The dotted lines show the 100% values and asterisk (*) indicates signiﬁcant difference from 4N (Pb0.05).
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presence of sodium compared with choline, and there was substrate
protection, which completely prevented inhibition by MTSET. The
G356Cmutant was inhibited by MTSET under all conditions, but there
was more inhibition in the absence of sodium. There was no evidence
of substrate protection of MTSET labeling in G356C.
Three of the cysteinemutants in the putative extracellular loopwere
treated with MTSEA-biotin, followed by detection of biotinylated4N Y322C
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Fig. 5. Succinate:citrate transport speciﬁcity ratio (TSR) inTM7cysteinemutants ofNaDC1.
Dual-label competitive transport assays were conducted with 10 μM [3 H]-succinate and
20 μM [14C]-citrate, as described in Methods. The data shown are means±SEM, n=2–4
(mutants) or 10 experiments (4N). The asterisk (*) denotes signiﬁcant difference from4N,
Pb0.05.proteins by Western blotting. As shown in Fig. 9, the positive control
mutant, T482C, was strongly labeled by MTSEA-biotin and the labeling
was prevented by preincubation withMTSET. However, there was little
or no signal in H355C, G356C or W357C, indicating that these mutants
are difﬁcult to label from the outside of the cell. Although low protein
expressioncould account for lowMTSEA-biotin labeling, the cell-surface
protein expression of themutantswas similar to that of 4N (Figs. 2, 3). It
is possible that the larger size of MTSEA-biotin accounts for the lack of
labeling of G356C.[Succinate] µM
0 150 300 450 600 750
Up
ta
ke
 (p
mo
l/m
in-
we
ll)
0
5
10
15
20
F336C
4N
Fig. 6. Succinate kinetics in F336C mutant compared with 4N. The transport of [3H]-
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measured in the same batch of COS-7 cells expressing the parental transporter 4N or the
F336Cmutant. Eachdatapoint is themean±SEM,n=4replicates fromasingle experiment.
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Fig. 7. Succinate transport activity remaining after treatment with MTSET. COS-7 cells
expressing TM7mutants were pretreated 10 minwith 1 mMMTSET in sodium buffer or
sodium buffer alone (control). The succinate transport activity remaining after the
MTSET pretreatment was measured using 20 μM [14C]-succinate. The succinate
transport activity was expressed as a percentage of control samples treated with
buffer only. The data shown are means±SEM, n=3–4 (mutants), 8 (T482C) or 13
experiments (4N). The asterisk (*) denotes signiﬁcant difference from 4N, Pb0.05.
Fig. 9. Direct labeling of cysteine-substituted mutants with MTSEA-biotin. NaDC1
cysteine mutants in the putative extracellular loop and a mutant shown previously to
be sensitive to MTSET, T482C [32], were pretreated for 10 min with 1 mM MTSET (+)
or sodium buffer (−) followed by chemical labeling with MTSEA-biotin. The
biotinylated samples were transferred to Western blots as described in Methods. The
positions of size standards 60 and 80 kDa are shown. Some lanes have been removed
from the image, shown by a gap. The blot was probed with anti-NaDC1 polyclonal
antibodies at 1:1000 dilution.
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The current secondary structure model of NaDC1 contains 11 TM
with an intracellular amino terminus andanextracellularN-glycosylated
carboxyl terminus [7]. At present there are no high-resolution crystal
structures for any member of the DASS family [20] that includes the
mammalian SLC13 transporters and NaDC1. Therefore, much of our
knowledge about the structure and function of the SLC13 transporters
comes frommutagenesis studies. Our previous study involved a cysteine
scan of ten amino acids at the top of TM7 [12]; the present study was a
continuation of the cysteine scan in both directions. TM7 was chosen
because several of our previous studies showed that it contains
determinants of substrate afﬁnity [10,11].Mutant
4N T482C G356C
Up
ta
ke
 re
m
ai
ni
ng
 (%
 co
ntr
ol)
0
20
40
60
80
100
120
Na+
Choline
Na++Succinate
*
*
*
#
#
# #
#
Fig. 8. Effect of preincubation conditions on accessibility to MTSET. COS-7 cells
expressing 4N, T482C, or G356C were pretreated for 10 min with 1 mM MTSET. The
MTSET pretreatment was done in sodium buffer (as in Fig. 7), choline buffer, or sodium
buffer with 10 mM succinate. Control groups for each mutant were incubated in buffer
only. The succinate transport activity remaining after the MTSET pretreatment was
measured using 20 μM [14C]-succinate. The data shown are means±SEM, n=3
experiments. The asterisk (*) indicates signiﬁcant differences compared with the Na+
treatment within a group and number sign (#) indicates signiﬁcant differences from
the 4N group incubated under the same conditions, Pb0.05.Out of the 26 amino acids mutated to cysteine in the present study,
25 were insensitive to membrane-impermeant MTS reagents. There-
fore, the TM7 region of NaDC1 is likely to be an outer helix in at least
partial contact with the lipid bilayer. A lack of reactivity with
membrane-impermeant MTS reagents appears to be a feature of
outer helices of other transporters. Cysteine scans of the lactose
permease identiﬁed four helices with few or no residues that react
with cysteine-speciﬁc reagents [21]. These heliceswere later shown in
the high-resolution structure to be outer helices [22]. Cysteine
mutagenesis studies in the GLUT1 glucose transporter show that
TM6 is a functionally important outer helix that contains only one
residue that reacts with cysteine-speciﬁc reagents [23]. In contrast,
TM12 is an outer helix that provides stability to the structure of the
GLUT1 transporter without being involved in the function [24].
The G356C mutant of NaDC1 was inhibited by treatment with the
membrane-impermeant reagent, MTSET. Gly-356 is conserved in all
members of the family (Fig. 1B). Replacement of Gly-356 by Cys
reduced the transport activity considerably, and chemical labeling
with MTSET inhibited further. The adjacent residue in the sequence,
Trp-357, is also conserved in all members of the SLC13 family and the
W357C mutant was inactive despite high protein expression on the
plasma membrane. These residues are located in a predicted
extracellular loop (Fig. 10), although this loop does not appear to be
readily accessible to more bulky reagents such as MTSEA-biotin. It is
possible that the loop region is required for ﬂexibility of the
transporter during the conformational changes in the transport
cycle. Glycine-301 in a loop region of the Na+/betaine symporter is
thought to be important for the ﬂexibility of the loop and may act as a
pivot point during conformational changes in the protein [25]. Glycine
residues have also been shown to act as hinges in helices of ion
channels and transporters [26–28].
Arg-349 at the outer surface of TM7 was identiﬁed in our previous
study as important for function [11,29]. The R349C mutant had
decreased activity. Although this mutant was not sensitive to MTSET,
the activity of the mutant could be restored by chemical modiﬁcation
with MTSEA. Cysteine modiﬁcation by MTSEA is very similar in
volume and charge to an arginine substitution [30]. Arg-349 is
accessible to the outside of the cell in the conformational state seen in
the presence of sodium, because there was no effect of MTSEA unless
sodium was present. In the present study, G356C was inhibited by
MTSET treatment in both sodium and choline, but the effect was
greater in choline. Therefore, Gly-356 may be more accessible to the
outside in the absence rather than the presence of sodium. The results
of the current and previous studies with TM7 suggest that the outer
portion of the helix and the loop are accessible to the outside, but the
rest of the helix may be inaccessible to the extracellular solvent.
Only one of the cysteine mutants, F336C, had increased transport
activity relative to that of the 4N parental transporter. This was found
to be due to an increased Vmax value that was approximately double
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Fig. 10. Model showing functionally important residues in TM7 and associated loops.
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shown by a black background, and the mutants with low transport activity have a dark
grey background, both with white lettering. The location of G356C (sensitive to
MTSET), R349C (sensitive to MTSEA), F339C (altered substrate selectivity), and F336C
(altered Vmax) are indicated by labels.
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membrane was slightly lower in F336C, indicating that the increased
Vmax is likely due to faster turnover. Phe-336 is not a conserved
residue, although the high-afﬁnity NaDC3 also contains Phe at this
position. As shown in the model (Fig. 10), Phe-336 is located
approximately one turn of the helix below Phe-339, a conserved
residue that had an altered succinate:citrate selectivity after mutation
to cysteine. It is possible that this face of the helix is functionally
important. Unfortunately, the transport activity of F339C mutant was
too low for further kinetic analysis.
The cysteine scan of TM7 revealed a surprisingly large number of
mutants with little or no activity, despite good expression on the
plasma membrane. Therefore, this TM appears to be more important
for function than for protein targeting. This region of NaDC1 contains a
large number of conserved residues (Fig. 1B), which may also indicate
the functional importance of this domain. For example, Pro-327 is a
conserved residue in NaDC1 and the P327C mutant also had very low
transport activity. The protein does not appear to tolerate substitu-
tions of this residue, which may be important for the structure or
stability of NaDC1. Alanine or glycine substitutions of Pro-327 also
resulted in very low activity and protein expression [9]. However,
some conserved residues were inactive when mutated to cysteine but
were able to tolerate other substitutions. For example, the E332C
mutant proteinwasmore abundant on the plasmamembrane than the
4N parental but there was no transport activity. However, an alanine
substitution at position 332 did not change succinate kinetics [31],
indicating that the lack of activity in the E332C mutant is not due to
chargeneutralization. The adjacent residue in the sequence, Lys-333, is
located approximately 100° away in the helix (Fig. 8). This residue is
conserved in the NaDC1 orthologs, but Ile or Gln can be found at thisposition in other members of the family. The K333C mutant was also
expressed on the plasma membrane but had decreased activity. In
contrast, a previous study showed that alanine is tolerated at this
position; the K333A mutant had a similar Km to the wild-type but an
increased Vmax [11].
In conclusion, this study focused on TM7 of NaDC1, a highly
conserved region of the protein that contains determinants of
substrate and sodium binding afﬁnity [10,11], as well as the
conformationally sensitive residue Arg-349 [12]. The results of the
present study showed that Gly-356 is functionally important and
accessible to the outside of the cell, but the rest of TM7 appears to be
inaccessible to the extracellular solvent. Many of the TM7 cysteine
mutants had high protein expression on the plasma membrane but
low or no activity, with the exception of F339C, which resulted in
increased transport Vmax. TM7 is likely to be an outer helix that does
not directly form the substrate permeation pathway but contains
amino acids that are important for function.
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